The California Institute for Regenerative Medicine (CIRM) is pleased to announce ReMIND-L, the first funding opportunity under CIRM’s ReMIND Program – a new discovery stage initiative supporting foundational research in the study of neuropsychiatric diseases.
Applications are due March 5, 2024 by 2:00 p.m. PST. Applications will be available mid-December 2023 but no later than two months prior to the submission deadline.
The ReMIND-L Request for Application supports expansive, cross-disciplinary, multi-investigator projects that propose impactful or innovative research that would:
- Uncover novel mechanistic insights into the pathobiology of neuropsychiatric disorders or further current understanding of disease mechanisms,
- Address major bottlenecks in the study of neuropsychiatric disorders,
- Extend understanding of neuropsychiatric disease mechanisms to diverse human populations, or
- Identify and/or validate novel therapeutic hypotheses, targets or biomarkers for the treatment of neuropsychiatric disorders.
Please download the ReMIND-L Request for Applications and read about program requirements before submitting your application.
To assist applicants, CIRM also plans to conduct a live webinar and Q&A session on this opportunity on Jan 8, 2024. Please register here to attend. Recordings of the webinar and FAQs will be posted here no later than 1 week after the live webinar.